Larimar Therapeutics Announces Pricing of Underwritten Public Offering

Larimar Therapeutics Announces Proposed Underwritten Public Offering

Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board

Biotech startup looks to turn founders' experience, $20 million against epilepsy

Research Associate, Biomarkers

Montara Therapeutics, Inc. is a preclinical-stage biopharmaceutical company focused on developing innovative therapies for neurological diseases. The Research Associate, Biomarkers, will contribute to biomarker and discovery efforts by developing and executing assays, collaborating with teams, and implementing new technologies.

Sign up with Google

Sign in with Google